Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:APT NASDAQ:GUTS NASDAQ:ICCM NASDAQ:INBS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPTAlpha Pro Tech$4.82-0.6%$4.76$4.06▼$6.20$50.48M0.2426,860 shs10,554 shsGUTSFractyl Health$0.990.0%$1.50$0.83▼$3.72$49.79M1.66502,374 shs544,034 shsICCMIceCure Medical$1.19+20.8%$0.97$0.48▼$1.66$69.85M0.32756,428 shs17.19 million shsINBSIntelligent Bio Solutions$1.65+3.8%$1.69$1.10▼$3.00$14.82M4.59173,066 shs200,504 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPTAlpha Pro Tech-0.21%+4.98%+1.68%+3.41%-22.03%GUTSFractyl Health-1.98%+1.02%-49.75%-47.89%-71.63%ICCMIceCure Medical+0.92%+15.18%-4.36%-4.36%+42.77%INBSIntelligent Bio Solutions+8.68%+11.19%+3.92%+6.71%+32.50%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPTAlpha Pro Tech0.6952 of 5 stars0.03.00.00.00.00.81.9GUTSFractyl Health2.4603 of 5 stars3.52.00.00.03.81.70.0ICCMIceCure Medical1.9293 of 5 stars3.52.00.00.02.50.00.6INBSIntelligent Bio Solutions0.384 of 5 stars0.02.00.00.03.00.00.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPTAlpha Pro Tech 0.00N/AN/AN/AGUTSFractyl Health 3.00Buy$6.53559.93% UpsideICCMIceCure Medical 3.00Buy$2.39100.42% UpsideINBSIntelligent Bio Solutions 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest INBS, ICCM, GUTS, and APT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/28/2025GUTSFractyl HealthLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$3.608/15/2025ICCMIceCure MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$2.50 ➝ $2.008/15/2025ICCMIceCure MedicalZacks ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/14/2025GUTSFractyl HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$12.00 ➝ $6.008/13/2025ICCMIceCure MedicalBrookline Capital ManagementSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy8/13/2025ICCMIceCure MedicalLoop CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price Target$2.775/29/2025ICCMIceCure MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$2.50(Data available from 8/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPTAlpha Pro Tech$58.56M0.86$0.38 per share12.80$5.29 per share0.91GUTSFractyl Health$17K2,928.59N/AN/A($0.36) per share-2.75ICCMIceCure Medical$3.29M21.23N/AN/A$0.05 per share23.80INBSIntelligent Bio Solutions$3.05M4.86N/AN/A$0.31 per share5.32Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPTAlpha Pro Tech$4.19M$0.3413.03∞N/A6.99%6.70%5.76%N/AGUTSFractyl Health-$68.69M-$2.06N/AN/AN/A-73,864.52%-584.35%-102.88%11/11/2025 (Estimated)ICCMIceCure Medical-$15.32M-$0.16N/AN/AN/A-317.62%-136.96%-71.46%N/AINBSIntelligent Bio Solutions-$10.57M-$2.05N/A4.71N/A-346.22%-231.13%-108.24%11/6/2025 (Estimated)Latest INBS, ICCM, GUTS, and APT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/15/2025Q4 2025INBSIntelligent Bio Solutions-$0.12-$0.37-$0.25-$0.41$4.30 million$0.84 million8/13/2025Q2 2025ICCMIceCure Medical-$0.06$0.06+$0.12$0.06$0.90 million$0.66 million8/12/2025Q2 2025GUTSFractyl Health-$0.37-$0.53-$0.16-$0.57N/AN/A5/28/2025Q1 2025ICCMIceCure Medical-$0.08-$0.06+$0.02-$0.06$0.75 million$0.73 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPTAlpha Pro TechN/AN/AN/AN/AN/AGUTSFractyl HealthN/AN/AN/AN/AN/AICCMIceCure MedicalN/AN/AN/AN/AN/AINBSIntelligent Bio SolutionsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPTAlpha Pro TechN/A19.0011.21GUTSFractyl Health4.611.221.22ICCMIceCure Medical0.021.180.88INBSIntelligent Bio SolutionsN/A0.770.65Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPTAlpha Pro Tech22.69%GUTSFractyl HealthN/AICCMIceCure Medical0.62%INBSIntelligent Bio Solutions32.97%Insider OwnershipCompanyInsider OwnershipAPTAlpha Pro Tech15.00%GUTSFractyl Health27.00%ICCMIceCure Medical2.44%INBSIntelligent Bio Solutions1.54%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPTAlpha Pro Tech12010.47 million9.46 millionOptionableGUTSFractyl Health10250.29 million36.71 millionN/AICCMIceCure Medical6058.70 million57.27 millionNot OptionableINBSIntelligent Bio Solutions108.98 million8.84 millionNot OptionableINBS, ICCM, GUTS, and APT HeadlinesRecent News About These CompaniesIntelligent Bio Solutions files to sell 4.15M shares of common stock for holdersAugust 23, 2025 | msn.comIntelligent Bio achieves monthly sales of 12,500+ units of cartridges in JulyAugust 19, 2025 | msn.comIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in JulyAugust 19, 2025 | finanznachrichten.deIntelligent Bio Solutions Inc. Achieves Record Sales of Over 12,500 Cartridges in July 2025August 19, 2025 | quiverquant.comQIntelligent Bio Solutions Achieves Record Monthly Sales of 12,500+ Units of Higher-Margin Cartridges in JulyAugust 19, 2025 | globenewswire.comIntelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased ...August 15, 2025 | taiwannews.com.twTIntelligent Bio Solutions reports FY25 EPS ($2.00) vs. ($6.38) last yearAugust 15, 2025 | msn.comIntelligent Bio Solutions Inc. Advances FDA Clearance Efforts and Reports 16% Revenue Growth in Q4 2025August 15, 2025 | quiverquant.comQIntelligent Bio Solutions Reports Fiscal 2025 Fourth Quarter and Full Year Results, Highlighting Progress on Planned U.S. Market Expansion, Revenue Growth and Increased Operational EfficienciesAugust 15, 2025 | globenewswire.comIntelligent Bio Solutions Submits Key FDA InformationAugust 13, 2025 | theglobeandmail.comIntelligent Bio Solutions to Participate in the Sidoti Micro-Cap Virtual Conference on August 20-21, 2025August 12, 2025 | globenewswire.comIntelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational MomentumAugust 7, 2025 | globenewswire.comIntelligent Bio Solutions Strengthens FDA 510(k) Package with New Cybersecurity and Performance Data Ahead of Planned U.S. Market LaunchAugust 6, 2025 | globenewswire.comIntelligent Bio Solutions Secures Major Drug Testing Tender with Leading London Transport OperatorJuly 30, 2025 | globenewswire.comIntelligent Bio Solutions Inc. Enters Into Agreements to Raise $3.8 Million in Gross ProceedsJuly 25, 2025 | globenewswire.comEXCLUSIVE: Intelligent Bio Solutions' New Data Confirms Ability To Detect Trace Sweat Volumes At Ultra-Micro LevelJuly 24, 2025 | benzinga.comIntelligent Bio Solutions to Strengthen FDA 510(k) Submission with New Positive Data Demonstrating Ultra-Precise Fingerprint Sweat Detection and Platform ResilienceJuly 23, 2025 | globenewswire.comIntelligent Bio Solutions Launches SmarTest Patch for Drug TestingJuly 18, 2025 | theglobeandmail.comIntelligent Bio Solutions Announces Global Distribution DealJuly 18, 2025 | theglobeandmail.comIntelligent Bio Solutions Accelerates Global Growth with SmarTest® Patch Agreement, Reinforces U.S. Expansion Path as FDA Approval Remains a Strategic PriorityJuly 16, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeINBS, ICCM, GUTS, and APT Company DescriptionsAlpha Pro Tech NYSE:APT$4.82 -0.03 (-0.62%) Closing price 04:00 PM EasternExtended Trading$4.79 -0.03 (-0.62%) As of 05:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Alpha Pro Tech, Ltd., together with its subsidiaries, develops, manufactures, and markets a range of disposable protective apparel, infection control, and building supply products in the United States and internationally. The company operates through Disposable Protective Apparel and Building Supply segments. The Disposable Protective Apparel segment provides shoe covers, bouffant caps, coveralls, frocks, lab coats, and gowns, hoods, as well as face masks and shields. The Building Supply segment offers construction weatherization products, such as housewrap and housewrap accessories, including window and door flashing, and seam tape, synthetic roof underlayment, and self-adhered roof underlayment, as well as other woven material. The company markets its products under the Alpha Pro Tech brand name, as well as under private labels. Its products are used primarily in cleanrooms; industrial safety manufacturing environments; health care facilities, such as hospitals, laboratories, and dental offices; building and re-roofing sites. The company distributes its products through a network of purchasing groups, distributors, and independent sales representatives, as well as through its sales and marketing force. Alpha Pro Tech, Ltd. was founded in 1983 and is headquartered in Markham, Canada.Fractyl Health NASDAQ:GUTS$0.99 0.00 (-0.04%) Closing price 04:00 PM EasternExtended Trading$1.00 +0.01 (+0.51%) As of 05:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.IceCure Medical NASDAQ:ICCM$1.19 +0.20 (+20.80%) Closing price 04:00 PM EasternExtended Trading$1.19 +0.00 (+0.17%) As of 05:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.Intelligent Bio Solutions NASDAQ:INBS$1.65 +0.06 (+3.77%) Closing price 04:00 PM EasternExtended Trading$1.62 -0.02 (-1.52%) As of 05:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CrowdStrike at a Crossroads: AI Halo vs. Risks NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor NVIDIA Stock Could Pull Back in September, But Don’t Bet on It NIO Just Got Its Second Upgrade of the Month, and It’s Big As Bitcoin Falls and Ethereum Rallies, Coinbase Stock Comes Back Williams-Sonoma Q2 Results Prove Its Buy-and-Hold Quality Okta: Market Comes to a Boil, Explosive Upside Is Possible MongoDB Roars Back to Life: It’s Not Too Late to Buy More Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.